Optimization of pretransplant amiodarone therapy to prevent primary graft dysfunction following heart transplantation
Discontinuing amiodarone closer to HT significantly reduces severe PGD without compromising long-term recipient or graft survival. This timing strategy may further optimize perioperative outcomes in donation after circulatory death recipients.
Authors
- Jay Patel (ORCID: https://orcid.org/0000-0002-6369-2759)
- Zubair A. Hashmi (ORCID: https://orcid.org/0009-0002-8907-1210)
- Keyur B. Shah (ORCID: https://orcid.org/0000-0002-8329-2963)
- Zachary W. Fitch (ORCID: https://orcid.org/0000-0002-1395-1513)
- Josue Chery
- Patricia Nicolato
- Kelli Fox
- Mohammed Quader (ORCID: https://orcid.org/0000-0001-8290-043X)
- Alan Lai
- Ye In Christopher Kwon
- Vigneshwar Kasirajan (ORCID: https://orcid.org/0000-0002-1974-7951)
- Inna Tchoukina (ORCID: https://orcid.org/0000-0002-1587-1998)
- Matthew Ambrosio
- Michael Keller
Institutions
- Virginia Commonwealth University (US)
Publication Details
- Journal
- JHLT Open
- Published
- 2025-09-23
- DOI
- https://doi.org/10.1016/j.jhlto.2025.100390
- Citations
- 1
- Primary Topic
- Transplantation: Methods and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 2.01